Smoking Cessation Alters Intestinal Microbiota: Insights from Quantitative Investigations on Human Fecal Samples Using FISH

There has been a dramatic increase in investigations on the potential mechanistic role of the intestinal microbiota in various diseases and factors modulating intestinal microbial composition. We recently reported on intestinal microbial shifts after smoking cessation in humans. In this study, we ai...

Full description

Saved in:
Bibliographic Details
Published inInflammatory bowel diseases Vol. 20; no. 9; pp. 1496 - 1501
Main Authors Biedermann, Luc, Brülisauer, Karin, Zeitz, Jonas, Frei, Pascal, Scharl, Michael, Vavricka, Stephan R., Fried, Michael, Loessner, Martin J., Rogler, Gerhard, Schuppler, Markus
Format Journal Article
LanguageEnglish
Published Oxford, UK Oxford University Press 01.09.2014
Subjects
Online AccessGet full text

Cover

Loading…
Abstract There has been a dramatic increase in investigations on the potential mechanistic role of the intestinal microbiota in various diseases and factors modulating intestinal microbial composition. We recently reported on intestinal microbial shifts after smoking cessation in humans. In this study, we aimed to conduct further microbial analyses and verify our previous results obtained by pyrosequencing using a direct quantitative microbial approach.MethodsStool samples of healthy smoking human subjects undergoing controlled smoking cessation during a 9-week observational period were analyzed and compared with 2 control groups, ongoing smoking and nonsmoking subjects. Fluorescence in situ hybridization was applied to quantify specific bacterial groups.ResultsIntestinal microbiota composition was substantially altered after smoking cessation as characterized by an increase in key representatives from the phyla of Firmicutes (Clostridium coccoides, Eubacterium rectale, and Clostridium leptum subgroup) and Actinobacteria (HGC bacteria and Bifidobacteria) as well as a decrease in Bacteroidetes (Prevotella spp. and Bacteroides spp.) and Proteobacteria (β- and γ-subgroup of Proteobacteria).ConclusionsAs determined by fluorescence in situ hybridization, an independent direct quantitative microbial approach, we could confirm that intestinal microbiota composition in humans is influenced by smoking. The characteristics of observed microbial shifts suggest a potential mechanistic association to alterations in body weight subsequent to smoking cessation. More importantly, regarding previously described microbial hallmarks of dysbiosis in inflammatory bowel diseases, a variety of observed microbial alterations after smoking cessation deserve further consideration in view of the divergent effect of smoking on the clinical course of Crohn's disease and ulcerative colitis.
AbstractList There has been a dramatic increase in investigations on the potential mechanistic role of the intestinal microbiota in various diseases and factors modulating intestinal microbial composition. We recently reported on intestinal microbial shifts after smoking cessation in humans. In this study, we aimed to conduct further microbial analyses and verify our previous results obtained by pyrosequencing using a direct quantitative microbial approach. Stool samples of healthy smoking human subjects undergoing controlled smoking cessation during a 9-week observational period were analyzed and compared with 2 control groups, ongoing smoking and nonsmoking subjects. Fluorescence in situ hybridization was applied to quantify specific bacterial groups. Intestinal microbiota composition was substantially altered after smoking cessation as characterized by an increase in key representatives from the phyla of Firmicutes (Clostridium coccoides, Eubacterium rectale, and Clostridium leptum subgroup) and Actinobacteria (HGC bacteria and Bifidobacteria) as well as a decrease in Bacteroidetes (Prevotella spp. and Bacteroides spp.) and Proteobacteria (β- and γ-subgroup of Proteobacteria). As determined by fluorescence in situ hybridization, an independent direct quantitative microbial approach, we could confirm that intestinal microbiota composition in humans is influenced by smoking. The characteristics of observed microbial shifts suggest a potential mechanistic association to alterations in body weight subsequent to smoking cessation. More importantly, regarding previously described microbial hallmarks of dysbiosis in inflammatory bowel diseases, a variety of observed microbial alterations after smoking cessation deserve further consideration in view of the divergent effect of smoking on the clinical course of Crohn's disease and ulcerative colitis.
BackgroundThere has been a dramatic increase in investigations on the potential mechanistic role of the intestinal microbiota in various diseases and factors modulating intestinal microbial composition. We recently reported on intestinal microbial shifts after smoking cessation in humans. In this study, we aimed to conduct further microbial analyses and verify our previous results obtained by pyrosequencing using a direct quantitative microbial approach.MethodsStool samples of healthy smoking human subjects undergoing controlled smoking cessation during a 9-week observational period were analyzed and compared with 2 control groups, ongoing smoking and nonsmoking subjects. Fluorescence in situ hybridization was applied to quantify specific bacterial groups.ResultsIntestinal microbiota composition was substantially altered after smoking cessation as characterized by an increase in key representatives from the phyla of Firmicutes (Clostridium coccoides, Eubacterium rectale, and Clostridium leptum subgroup) and Actinobacteria (HGC bacteria and Bifidobacteria) as well as a decrease in Bacteroidetes (Prevotella spp. and Bacteroides spp.) and Proteobacteria (β- and γ-subgroup of Proteobacteria).ConclusionsAs determined by fluorescence in situ hybridization, an independent direct quantitative microbial approach, we could confirm that intestinal microbiota composition in humans is influenced by smoking. The characteristics of observed microbial shifts suggest a potential mechanistic association to alterations in body weight subsequent to smoking cessation. More importantly, regarding previously described microbial hallmarks of dysbiosis in inflammatory bowel diseases, a variety of observed microbial alterations after smoking cessation deserve further consideration in view of the divergent effect of smoking on the clinical course of Crohn's disease and ulcerative colitis.
Background: There has been a dramatic increase in investigations on the potential mechanistic role of the intestinal microbiota in various diseases and factors modulating intestinal microbial composition. We recently reported on intestinal microbial shifts after smoking cessation in humans. In this study, we aimed to conduct further microbial analyses and verify our previous results obtained by pyrosequencing using a direct quantitative microbial approach. Methods: Stool samples of healthy smoking human subjects undergoing controlled smoking cessation during a 9-week observational period were analyzed and compared with 2 control groups, ongoing smoking and nonsmoking subjects. Fluorescence in situ hybridization was applied to quantify specific bacterial groups. Results: Intestinal microbiota composition was substantially altered after smoking cessation as characterized by an increase in key representatives from the phyla of Firmicutes (Clostridium coccoides, Eubacterium rectale, and Clostridium leptum subgroup) and Actinobacteria (HGC bacteria and Bifidobacteria) as well as a decrease in Bacteroidetes (Prevotella spp. and Bacteroides spp.) and Proteobacteria ( beta - and gamma -subgroup of Proteobacteria). Conclusions: As determined by fluorescence in situ hybridization, an independent direct quantitative microbial approach, we could confirm that intestinal microbiota composition in humans is influenced by smoking. The characteristics of observed microbial shifts suggest a potential mechanistic association to alterations in body weight subsequent to smoking cessation. More importantly, regarding previously described microbial hallmarks of dysbiosis in inflammatory bowel diseases, a variety of observed microbial alterations after smoking cessation deserve further consideration in view of the divergent effect of smoking on the clinical course of Crohn's disease and ulcerative colitis.
There has been a dramatic increase in investigations on the potential mechanistic role of the intestinal microbiota in various diseases and factors modulating intestinal microbial composition. We recently reported on intestinal microbial shifts after smoking cessation in humans. In this study, we aimed to conduct further microbial analyses and verify our previous results obtained by pyrosequencing using a direct quantitative microbial approach.BACKGROUNDThere has been a dramatic increase in investigations on the potential mechanistic role of the intestinal microbiota in various diseases and factors modulating intestinal microbial composition. We recently reported on intestinal microbial shifts after smoking cessation in humans. In this study, we aimed to conduct further microbial analyses and verify our previous results obtained by pyrosequencing using a direct quantitative microbial approach.Stool samples of healthy smoking human subjects undergoing controlled smoking cessation during a 9-week observational period were analyzed and compared with 2 control groups, ongoing smoking and nonsmoking subjects. Fluorescence in situ hybridization was applied to quantify specific bacterial groups.METHODSStool samples of healthy smoking human subjects undergoing controlled smoking cessation during a 9-week observational period were analyzed and compared with 2 control groups, ongoing smoking and nonsmoking subjects. Fluorescence in situ hybridization was applied to quantify specific bacterial groups.Intestinal microbiota composition was substantially altered after smoking cessation as characterized by an increase in key representatives from the phyla of Firmicutes (Clostridium coccoides, Eubacterium rectale, and Clostridium leptum subgroup) and Actinobacteria (HGC bacteria and Bifidobacteria) as well as a decrease in Bacteroidetes (Prevotella spp. and Bacteroides spp.) and Proteobacteria (β- and γ-subgroup of Proteobacteria).RESULTSIntestinal microbiota composition was substantially altered after smoking cessation as characterized by an increase in key representatives from the phyla of Firmicutes (Clostridium coccoides, Eubacterium rectale, and Clostridium leptum subgroup) and Actinobacteria (HGC bacteria and Bifidobacteria) as well as a decrease in Bacteroidetes (Prevotella spp. and Bacteroides spp.) and Proteobacteria (β- and γ-subgroup of Proteobacteria).As determined by fluorescence in situ hybridization, an independent direct quantitative microbial approach, we could confirm that intestinal microbiota composition in humans is influenced by smoking. The characteristics of observed microbial shifts suggest a potential mechanistic association to alterations in body weight subsequent to smoking cessation. More importantly, regarding previously described microbial hallmarks of dysbiosis in inflammatory bowel diseases, a variety of observed microbial alterations after smoking cessation deserve further consideration in view of the divergent effect of smoking on the clinical course of Crohn's disease and ulcerative colitis.CONCLUSIONSAs determined by fluorescence in situ hybridization, an independent direct quantitative microbial approach, we could confirm that intestinal microbiota composition in humans is influenced by smoking. The characteristics of observed microbial shifts suggest a potential mechanistic association to alterations in body weight subsequent to smoking cessation. More importantly, regarding previously described microbial hallmarks of dysbiosis in inflammatory bowel diseases, a variety of observed microbial alterations after smoking cessation deserve further consideration in view of the divergent effect of smoking on the clinical course of Crohn's disease and ulcerative colitis.
There has been a dramatic increase in investigations on the potential mechanistic role of the intestinal microbiota in various diseases and factors modulating intestinal microbial composition. We recently reported on intestinal microbial shifts after smoking cessation in humans. In this study, we aimed to conduct further microbial analyses and verify our previous results obtained by pyrosequencing using a direct quantitative microbial approach.MethodsStool samples of healthy smoking human subjects undergoing controlled smoking cessation during a 9-week observational period were analyzed and compared with 2 control groups, ongoing smoking and nonsmoking subjects. Fluorescence in situ hybridization was applied to quantify specific bacterial groups.ResultsIntestinal microbiota composition was substantially altered after smoking cessation as characterized by an increase in key representatives from the phyla of Firmicutes (Clostridium coccoides, Eubacterium rectale, and Clostridium leptum subgroup) and Actinobacteria (HGC bacteria and Bifidobacteria) as well as a decrease in Bacteroidetes (Prevotella spp. and Bacteroides spp.) and Proteobacteria (β- and γ-subgroup of Proteobacteria).ConclusionsAs determined by fluorescence in situ hybridization, an independent direct quantitative microbial approach, we could confirm that intestinal microbiota composition in humans is influenced by smoking. The characteristics of observed microbial shifts suggest a potential mechanistic association to alterations in body weight subsequent to smoking cessation. More importantly, regarding previously described microbial hallmarks of dysbiosis in inflammatory bowel diseases, a variety of observed microbial alterations after smoking cessation deserve further consideration in view of the divergent effect of smoking on the clinical course of Crohn's disease and ulcerative colitis.
Author Brülisauer, Karin
Zeitz, Jonas
Frei, Pascal
Rogler, Gerhard
Vavricka, Stephan R.
Fried, Michael
Schuppler, Markus
Biedermann, Luc
Loessner, Martin J.
Scharl, Michael
Author_xml – sequence: 1
  givenname: Luc
  surname: Biedermann
  fullname: Biedermann, Luc
  organization: Division of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland
– sequence: 2
  givenname: Karin
  surname: Brülisauer
  fullname: Brülisauer, Karin
  organization: †Institute of Food, Nutrition and Health, ETH Zurich, Zurich, Switzerland
– sequence: 3
  givenname: Jonas
  surname: Zeitz
  fullname: Zeitz, Jonas
  organization: Division of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland
– sequence: 4
  givenname: Pascal
  surname: Frei
  fullname: Frei, Pascal
  organization: Division of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland
– sequence: 5
  givenname: Michael
  surname: Scharl
  fullname: Scharl, Michael
  organization: Division of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland
– sequence: 6
  givenname: Stephan R.
  surname: Vavricka
  fullname: Vavricka, Stephan R.
  organization: Division of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland
– sequence: 7
  givenname: Michael
  surname: Fried
  fullname: Fried, Michael
  organization: Division of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland
– sequence: 8
  givenname: Martin J.
  surname: Loessner
  fullname: Loessner, Martin J.
  organization: †Institute of Food, Nutrition and Health, ETH Zurich, Zurich, Switzerland
– sequence: 9
  givenname: Gerhard
  surname: Rogler
  fullname: Rogler, Gerhard
  organization: Division of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland
– sequence: 10
  givenname: Markus
  surname: Schuppler
  fullname: Schuppler, Markus
  organization: †Institute of Food, Nutrition and Health, ETH Zurich, Zurich, Switzerland
BackLink https://www.ncbi.nlm.nih.gov/pubmed/25072500$$D View this record in MEDLINE/PubMed
BookMark eNqNkV1rHCEYhSWk5Kv9B6EIvenNJDo6o-YuWbrdhYRStrkWdZyN6Yxu1QmU_vm62QTK3qSKvKLPOcp7TsGhD94CcI7RBUaCXd4tby7QvwPX4gCc4Ia0FeWUHpY9YrxCQvBjcJrSI0J1meIIHNcNYmWhE_BnNYafzq_hzKaksgseXg_ZxgSXPtuUnVcDvHMmBu1CVlflOLn1Q06wj2GE3yfls8tF-GTL1dNWsX62SbBYLaZReTi3ppis1LgZbIL3afvcfLlavAfvejUk--GlnoH7-Zcfs0V1--3rcnZ9WxmKeK503ykqiLW81twwTDVvGO7blhGlTE90R1THDVa6MUxQLVrKiTa1ol2LbWfIGfi8893E8GsqX5SjS8YOg_I2TEniliPacNGQt9GmIQxxxFlBP-2hj2GKpV1JEtwKJoSgW-rjCzXp0XZyE92o4m_5mkABrnZAaXFK0fbSPPcz-ByVGyRGchu3LHHL_biLmO6JX_3fkF3uZGHa_J_iLwxAuiY
CitedBy_id crossref_primary_10_5217_ir_2020_00008
crossref_primary_10_1080_00365521_2023_2255710
crossref_primary_10_1093_ibd_izaa152
crossref_primary_10_3390_metabo12030234
crossref_primary_10_1111_nmo_14157
crossref_primary_10_3389_fimmu_2020_02144
crossref_primary_10_3748_wjg_v21_i37_10609
crossref_primary_10_1097_MPG_0000000000000950
crossref_primary_10_3390_biomedicines12081645
crossref_primary_10_1007_s00415_019_09320_1
crossref_primary_10_1186_s13099_022_00524_x
crossref_primary_10_1097_IJ9_0000000000000051
crossref_primary_10_1038_s41467_024_44841_y
crossref_primary_10_1186_s12890_024_03045_2
crossref_primary_10_1002_mnfr_202400494
crossref_primary_10_1080_19768354_2024_2338855
crossref_primary_10_1016_j_nmni_2015_11_004
crossref_primary_10_3390_biomedicines11123144
crossref_primary_10_3390_nu12030880
crossref_primary_10_3390_biomedicines11041144
crossref_primary_10_1183_13993003_02320_2019
crossref_primary_10_1136_gutjnl_2019_319630
crossref_primary_10_3389_fmicb_2024_1465673
crossref_primary_10_3390_cancers15123200
crossref_primary_10_1016_S2468_1253_17_30031_6
crossref_primary_10_1038_s41598_021_83922_6
crossref_primary_10_1155_2018_4832912
crossref_primary_10_1016_j_gendis_2016_03_004
crossref_primary_10_1053_j_gastro_2017_05_010
crossref_primary_10_3389_fneur_2019_01155
crossref_primary_10_1007_s10482_020_01474_7
crossref_primary_10_1093_ntr_ntw030
crossref_primary_10_1016_j_disamonth_2017_07_001
crossref_primary_10_3233_JPD_150557
crossref_primary_10_1016_j_jad_2023_02_002
crossref_primary_10_1007_s00384_023_04468_9
crossref_primary_10_1016_j_bpg_2017_09_009
crossref_primary_10_1007_s40618_016_0594_6
crossref_primary_10_1038_d41586_021_03548_6
crossref_primary_10_1177_2397847317741884
crossref_primary_10_1371_journal_pone_0230895
crossref_primary_10_1007_s00203_018_1506_2
crossref_primary_10_3390_nu14091921
crossref_primary_10_1016_j_nut_2020_110797
crossref_primary_10_1007_s10620_019_05648_w
crossref_primary_10_1099_jmm_0_000331
crossref_primary_10_1016_j_cgh_2018_08_067
crossref_primary_10_1093_ecco_jcc_jjv113
crossref_primary_10_12998_wjcc_v6_i4_44
crossref_primary_10_1007_s11427_023_2446_y
crossref_primary_10_1093_ajcn_nqac128
crossref_primary_10_1007_s40618_019_1010_9
crossref_primary_10_1089_chi_2014_0113
crossref_primary_10_1186_s12889_019_7807_9
crossref_primary_10_1186_s12866_020_01907_3
crossref_primary_10_3748_wjg_v27_i22_2921
crossref_primary_10_1016_j_schres_2020_02_010
crossref_primary_10_1038_s41598_017_13739_9
crossref_primary_10_1016_j_disamonth_2019_02_004
crossref_primary_10_3390_jcm7090282
crossref_primary_10_1097_MIB_0000000000000875
crossref_primary_10_1136_gutjnl_2021_325021
crossref_primary_10_1002_brb3_3130
crossref_primary_10_1099_mic_0_000336
crossref_primary_10_1159_000524181
crossref_primary_10_3389_fnut_2024_1371064
crossref_primary_10_1042_CS20171110
crossref_primary_10_1111_apt_14338
crossref_primary_10_1128_AEM_01753_16
crossref_primary_10_1016_j_cgh_2018_07_012
crossref_primary_10_1016_j_pnpbp_2020_110076
crossref_primary_10_4081_reumatismo_2024_1572
crossref_primary_10_1016_j_lfs_2020_118616
crossref_primary_10_1016_j_suc_2015_07_006
crossref_primary_10_1080_01635581_2024_2367266
crossref_primary_10_1080_19490976_2017_1284733
crossref_primary_10_1042_CS20220175
crossref_primary_10_3390_nu11061398
crossref_primary_10_3389_fnut_2021_642509
crossref_primary_10_5662_wjm_v14_i1_89196
crossref_primary_10_1080_15412555_2021_2019208
crossref_primary_10_3390_ijerph13111075
crossref_primary_10_1016_j_cgh_2017_11_002
crossref_primary_10_1038_s41579_023_00998_9
crossref_primary_10_1183_23120541_00788_2023
crossref_primary_10_3390_jcm10071515
crossref_primary_10_1016_j_jaci_2019_11_003
crossref_primary_10_1038_s41531_023_00511_2
crossref_primary_10_1038_nrgastro_2015_34
crossref_primary_10_1111_apt_15774
crossref_primary_10_1016_j_atherosclerosis_2020_08_028
crossref_primary_10_1038_nrendo_2016_32
crossref_primary_10_1093_ije_dyy298
crossref_primary_10_3390_nu14224800
crossref_primary_10_1007_s40471_018_0167_7
crossref_primary_10_1016_j_cmet_2021_05_005
crossref_primary_10_1016_j_plabm_2017_09_001
crossref_primary_10_1111_resp_12971
crossref_primary_10_1530_EJE_14_0874
crossref_primary_10_7717_peerj_4693
crossref_primary_10_5607_en20047
crossref_primary_10_1007_s00296_015_3368_0
crossref_primary_10_3748_wjg_v26_i25_3611
crossref_primary_10_1152_physrev_00018_2018
crossref_primary_10_1136_bmjopen_2020_040117
crossref_primary_10_3389_fimmu_2018_00074
crossref_primary_10_1007_s00535_015_1064_1
crossref_primary_10_1111_codi_13748
crossref_primary_10_1002_jat_4338
crossref_primary_10_3390_nu15214661
crossref_primary_10_1093_gastro_goab046
crossref_primary_10_1016_j_ebiom_2021_103538
crossref_primary_10_1038_nrmicro_2016_142
crossref_primary_10_1016_j_gtc_2020_07_005
crossref_primary_10_1038_s41586_021_04194_8
crossref_primary_10_3390_ijms24010252
crossref_primary_10_18332_tid_194680
crossref_primary_10_1155_ijcp_5511146
crossref_primary_10_1016_j_anaerobe_2023_102787
crossref_primary_10_1159_000494696
crossref_primary_10_1007_s11892_017_0903_2
crossref_primary_10_1111_jgh_16497
Cites_doi 10.1371/journal.pbio.0060280
10.1053/gast.1996.v110.pm8566589
10.1038/nrmicro1888
10.1136/gut.2005.073817
10.1002/ibd.20828
10.1126/science.1237439
10.1053/j.gastro.2007.04.005
10.1002/cyto.990140205
10.1038/nature11450
10.1128/AEM.61.8.3069-3075.1995
10.1128/AEM.68.6.2982-2990.2002
10.1038/nature11234
10.1126/science.1179721
10.1038/nature05414
10.1007/s10620-009-0934-x
10.1093/oxfordjournals.aje.a009706
10.1099/jmm.0.46498-0
10.1073/pnas.1000087107
10.1002/ibd.21864
10.1128/AEM.64.9.3336-3345.1998
10.1099/00221287-140-10-2849
10.1111/j.1572-0241.2001.03944.x
10.1016/S0167-7012(00)00152-4
10.1073/pnas.1011383107
10.1126/science.276.5313.734
10.1099/13500872-142-5-1097
10.1016/0306-4603(87)90045-1
10.1038/nature10554
10.1128/jb.172.2.762-770.1990
10.1002/hep.26319
10.1073/pnas.0407076101
10.1038/nature12198
10.4065/81.11.1462
10.1136/gut.2010.223263
10.1073/pnas.0504978102
10.1128/AEM.66.5.2263-2266.2000
ContentType Journal Article
Copyright Copyright © 2014 Crohn's & Colitis Foundation of America, Inc. 2014
Copyright © 2014 Crohn's & Colitis Foundation of America, Inc.
Copyright_xml – notice: Copyright © 2014 Crohn's & Colitis Foundation of America, Inc. 2014
– notice: Copyright © 2014 Crohn's & Colitis Foundation of America, Inc.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
BENPR
CCPQU
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
7T5
H94
DOI 10.1097/MIB.0000000000000129
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central
ProQuest One Community College
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni)
PML(ProQuest Medical Library)
ProQuest Central Premium
ProQuest One Academic
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
Immunology Abstracts
AIDS and Cancer Research Abstracts
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
ProQuest Health & Medical Research Collection
Health Research Premium Collection
ProQuest Medical Library
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
Health & Medical Research Collection
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Medical Library (Alumni)
ProQuest Central (Alumni)
MEDLINE - Academic
AIDS and Cancer Research Abstracts
Immunology Abstracts
DatabaseTitleList MEDLINE
ProQuest One Academic Middle East (New)
AIDS and Cancer Research Abstracts
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1536-4844
EndPage 1501
ExternalDocumentID 25072500
10_1097_MIB_0000000000000129
10.1097/MIB.0000000000000129
Genre Research Support, Non-U.S. Gov't
Journal Article
Observational Study
GroupedDBID ---
.Z2
0R~
1OC
3WU
48X
53G
5GY
5VS
5WD
66C
7O~
8-0
8UM
AAAXR
AABZA
AACZT
AAKAS
AAPQZ
AAPXW
AARHZ
AARTV
AAUAY
AAVAP
AAYEP
ABBUW
ABDFA
ABEJV
ABGNP
ABJNI
ABNHQ
ABOCM
ABPQP
ABPTD
ABQNK
ABVGC
ABWST
ABXVJ
ABXVV
ABZAD
ACDDN
ACEWG
ACGFO
ACGFS
ACUTJ
ACWDW
ACWRI
ACXNZ
ACYHN
ADBBV
ADBIZ
ADGZP
ADIPN
ADQBN
ADRTK
ADVEK
ADZCM
AENEX
AETBJ
AFFZL
AFOFC
AFTRI
AFUWQ
AFXAL
AGINJ
AGQXC
AGUTN
AHMBA
AHMMS
AIJEX
AIZYK
AJEEA
ALMA_UNASSIGNED_HOLDINGS
ATGXG
AWKKM
BAYMD
BCRHZ
BEYMZ
BOYCO
BTRTY
C45
CDBKE
CS3
DAKXR
DR2
DU5
E.X
E3Z
EBS
EJD
ENERS
EX3
F5P
FECEO
FL-
FLUFQ
FOEOM
FOTVD
FQBLK
GAUVT
GJXCC
H0~
HZ~
IN~
IX1
KBUDW
KOP
KSI
KSN
LAW
MHKGH
NNB
NOMLY
NOYVH
NVLIB
N~7
N~B
O9-
OAUYM
OCZFY
ODMLO
OIG
OJZSN
OPAEJ
OVD
OWPYF
P2P
PAFKI
PQQKQ
QRW
ROX
RUSNO
RX1
S4S
TEORI
V2E
WOW
XV2
YAYTL
YKOAZ
YXANX
ZFV
31~
4.4
7X7
8-1
88E
8F7
8FI
8FJ
AAJQQ
AAPGJ
AAUQX
AAWDT
AAYXX
ABUWG
ACFRR
ACVCV
ACXQS
ACZBC
ADMTO
ADNBA
AEMQT
AFBPY
AFFQV
AFKRA
AFYAG
AFZJQ
AGKRT
AGMDO
AGORE
AHGBF
AHRYX
AJAOE
AJBYB
AJDVS
AJNCP
AJNYG
ALXQX
APJGH
AQDSO
AQKUS
AVNTJ
BENPR
CCPQU
CITATION
EIHJH
FYUFA
H13
HMCUK
IAO
IHR
ITC
JXSIZ
LH4
LW6
M1P
MBLQV
NU-
OBFPC
OCUKA
ORVUJ
PHGZM
PHGZT
PSQYO
ROL
TMA
UKHRP
W99
WOQ
Y6R
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7XB
8FK
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
PRINS
7X8
7T5
H94
ID FETCH-LOGICAL-c408t-bfda493ee82b8c714b8571f6673aacf3bd3ad8c1ab5c794b96483bc2a4d61edc3
IEDL.DBID 7X7
ISSN 1078-0998
1536-4844
IngestDate Fri Jul 11 02:57:49 EDT 2025
Wed Jul 30 11:23:21 EDT 2025
Fri Jul 25 21:51:43 EDT 2025
Wed Feb 19 02:41:17 EST 2025
Thu Apr 24 23:09:47 EDT 2025
Tue Jul 01 04:19:46 EDT 2025
Sat Feb 08 08:13:09 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 9
Keywords fluorescence in situ hybridization
metabolic syndrome
intestinal microbiota
smoking cessation
inflammatory bowel disease
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c408t-bfda493ee82b8c714b8571f6673aacf3bd3ad8c1ab5c794b96483bc2a4d61edc3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Undefined-3
PMID 25072500
PQID 3169799947
PQPubID 996336
PageCount 6
ParticipantIDs proquest_miscellaneous_1680458953
proquest_miscellaneous_1553708087
proquest_journals_3169799947
pubmed_primary_25072500
crossref_citationtrail_10_1097_MIB_0000000000000129
crossref_primary_10_1097_MIB_0000000000000129
oup_primary_10_1097_MIB_0000000000000129
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2014-09-01
PublicationDateYYYYMMDD 2014-09-01
PublicationDate_xml – month: 09
  year: 2014
  text: 2014-09-01
  day: 01
PublicationDecade 2010
PublicationPlace Oxford, UK
PublicationPlace_xml – name: Oxford, UK
– name: England
– name: Baltimore
PublicationTitle Inflammatory bowel diseases
PublicationTitleAlternate Inflamm Bowel Dis
PublicationYear 2014
Publisher Oxford University Press
Publisher_xml – name: Oxford University Press
References Beaugerie (R22-2-20140815) 2001; 96
Kassinen (R12-2-20140815) 2007; 133
Manz (R33-2-20140815) 1996; 142
Bibiloni (R40-2-20140815) 2006; 55
Wallner (R31-2-20140815) 1993; 14
Dethlefsen (R17-2-20140815) 2011; 108
Franks (R28-2-20140815) 1998; 64
Benjamin (R39-2-20140815) 2012; 18
Ley (R3-2-20140815) 2005; 102
Joossens (R41-2-20140815) 2011; 60
Cosnes (R20-2-20140815) 1996; 110
Amann (R30-2-20140815) 1990; 172
Qin (R7-2-20140815) 2012; 490
Moter (R47-2-20140815) 2000; 41
Sghir (R36-2-20140815) 2000; 66
Berer (R9-2-20140815) 2011; 479
Amann (R27-2-20140815) 2008; 6
Mouzaki (R8-2-20140815) 2013; 58
Dethlefsen (R18-2-20140815) 2008; 6
Karlsson (R6-2-20140815) 2013; 498
Pace (R1-2-20140815) 1997; 276
(R15-2-20140815) 2012; 486
Koren (R10-2-20140815) 2011; 108
Langendijk (R34-2-20140815) 1995; 61
Mahid (R21-2-20140815) 2006; 81
OHara (R23-2-20140815) 1998; 148
Vijay-Kumar (R5-2-20140815) 2010; 328
Turnbaugh (R2-2-20140815) 2006; 444
Codling (R11-2-20140815) 2010; 55
Rodin (R25-2-20140815) 1987; 12
Seksik (R13-2-20140815) 2009; 15
Roller (R35-2-20140815) 1994; 140
Harmsen (R29-2-20140815) 2002; 68
Backhed (R4-2-20140815) 2004; 101
Manichanh (R43-2-20140815) 2006; 55
Faith (R16-2-20140815) 2013; 341
References_xml – volume: 6
  start-page: e280
  year: 2008
  ident: R18-2-20140815
  publication-title: PLoS Biol
  doi: 10.1371/journal.pbio.0060280
– volume: 110
  start-page: 424
  year: 1996
  ident: R20-2-20140815
  publication-title: Gastroenterology
  doi: 10.1053/gast.1996.v110.pm8566589
– volume: 6
  start-page: 339
  year: 2008
  ident: R27-2-20140815
  publication-title: Nat Rev Microbiol
  doi: 10.1038/nrmicro1888
– volume: 55
  start-page: 205
  year: 2006
  ident: R43-2-20140815
  publication-title: Gut
  doi: 10.1136/gut.2005.073817
– volume: 15
  start-page: 734
  year: 2009
  ident: R13-2-20140815
  publication-title: Inflamm Bowel Dis
  doi: 10.1002/ibd.20828
– volume: 341
  start-page: 1237439
  year: 2013
  ident: R16-2-20140815
  publication-title: Science
  doi: 10.1126/science.1237439
– volume: 133
  start-page: 24
  year: 2007
  ident: R12-2-20140815
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2007.04.005
– volume: 14
  start-page: 136
  year: 1993
  ident: R31-2-20140815
  publication-title: Cytometry
  doi: 10.1002/cyto.990140205
– volume: 490
  start-page: 55
  year: 2012
  ident: R7-2-20140815
  publication-title: Nature
  doi: 10.1038/nature11450
– volume: 61
  start-page: 3069
  year: 1995
  ident: R34-2-20140815
  publication-title: Appl Environ Microbiol
  doi: 10.1128/AEM.61.8.3069-3075.1995
– volume: 68
  start-page: 2982
  year: 2002
  ident: R29-2-20140815
  publication-title: Appl Environ Microbiol
  doi: 10.1128/AEM.68.6.2982-2990.2002
– volume: 486
  start-page: 207
  year: 2012
  ident: R15-2-20140815
  publication-title: Nature
  doi: 10.1038/nature11234
– volume: 328
  start-page: 228
  year: 2010
  ident: R5-2-20140815
  publication-title: Science
  doi: 10.1126/science.1179721
– volume: 444
  start-page: 1027
  year: 2006
  ident: R2-2-20140815
  publication-title: Nature
  doi: 10.1038/nature05414
– volume: 55
  start-page: 392
  year: 2010
  ident: R11-2-20140815
  publication-title: Dig Dis Sci
  doi: 10.1007/s10620-009-0934-x
– volume: 148
  start-page: 821
  year: 1998
  ident: R23-2-20140815
  publication-title: Am J Epidemiol
  doi: 10.1093/oxfordjournals.aje.a009706
– volume: 55
  start-page: 1141
  year: 2006
  ident: R40-2-20140815
  publication-title: J Med Microbiol
  doi: 10.1099/jmm.0.46498-0
– volume: 108
  start-page: 4554
  year: 2011
  ident: R17-2-20140815
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.1000087107
– volume: 18
  start-page: 1092
  year: 2012
  ident: R39-2-20140815
  publication-title: Inflamm Bowel Dis
  doi: 10.1002/ibd.21864
– volume: 64
  start-page: 3336
  year: 1998
  ident: R28-2-20140815
  publication-title: Appl Environ Microbiol
  doi: 10.1128/AEM.64.9.3336-3345.1998
– volume: 140
  start-page: 2849
  year: 1994
  ident: R35-2-20140815
  publication-title: Microbiology
  doi: 10.1099/00221287-140-10-2849
– volume: 96
  start-page: 2113
  year: 2001
  ident: R22-2-20140815
  publication-title: Am J Gastroenterol
  doi: 10.1111/j.1572-0241.2001.03944.x
– volume: 41
  start-page: 85
  year: 2000
  ident: R47-2-20140815
  publication-title: J Microbiol Methods
  doi: 10.1016/S0167-7012(00)00152-4
– volume: 108
  start-page: 4592
  year: 2011
  ident: R10-2-20140815
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.1011383107
– volume: 276
  start-page: 734
  year: 1997
  ident: R1-2-20140815
  publication-title: Science
  doi: 10.1126/science.276.5313.734
– volume: 142
  start-page: 1097
  year: 1996
  ident: R33-2-20140815
  publication-title: Microbiology
  doi: 10.1099/13500872-142-5-1097
– volume: 12
  start-page: 303
  year: 1987
  ident: R25-2-20140815
  publication-title: Addict Behav
  doi: 10.1016/0306-4603(87)90045-1
– volume: 479
  start-page: 538
  year: 2011
  ident: R9-2-20140815
  publication-title: Nature
  doi: 10.1038/nature10554
– volume: 172
  start-page: 762
  year: 1990
  ident: R30-2-20140815
  publication-title: J Bacteriol
  doi: 10.1128/jb.172.2.762-770.1990
– volume: 58
  start-page: 120
  year: 2013
  ident: R8-2-20140815
  publication-title: Hepatology
  doi: 10.1002/hep.26319
– volume: 101
  start-page: 15718
  year: 2004
  ident: R4-2-20140815
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.0407076101
– volume: 498
  start-page: 99
  year: 2013
  ident: R6-2-20140815
  publication-title: Nature
  doi: 10.1038/nature12198
– volume: 81
  start-page: 1462
  year: 2006
  ident: R21-2-20140815
  publication-title: Mayo Clin Proc
  doi: 10.4065/81.11.1462
– volume: 60
  start-page: 631
  year: 2011
  ident: R41-2-20140815
  publication-title: Gut
  doi: 10.1136/gut.2010.223263
– volume: 102
  start-page: 11070
  year: 2005
  ident: R3-2-20140815
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.0504978102
– volume: 66
  start-page: 2263
  year: 2000
  ident: R36-2-20140815
  publication-title: Appl Environ Microbiol
  doi: 10.1128/AEM.66.5.2263-2266.2000
SSID ssj0020209
Score 2.4820778
Snippet There has been a dramatic increase in investigations on the potential mechanistic role of the intestinal microbiota in various diseases and factors modulating...
BackgroundThere has been a dramatic increase in investigations on the potential mechanistic role of the intestinal microbiota in various diseases and factors...
Background: There has been a dramatic increase in investigations on the potential mechanistic role of the intestinal microbiota in various diseases and factors...
SourceID proquest
pubmed
crossref
oup
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1496
SubjectTerms Actinobacteria
Bacteroides
Clostridium coccoides
Clostridium leptum
Colony Count, Microbial
DNA, Bacterial - genetics
Eubacterium rectale
Feces - microbiology
Firmicutes
Humans
In Situ Hybridization, Fluorescence - methods
Intestines - microbiology
Microbiota
Oligonucleotide Probes
Prevotella
Proteobacteria
Smoking Cessation
Title Smoking Cessation Alters Intestinal Microbiota: Insights from Quantitative Investigations on Human Fecal Samples Using FISH
URI https://www.ncbi.nlm.nih.gov/pubmed/25072500
https://www.proquest.com/docview/3169799947
https://www.proquest.com/docview/1553708087
https://www.proquest.com/docview/1680458953
Volume 20
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3dT9swED8xkNBeJmCDdUBlpD3sJaKpndjhBVGgKkhFWwtS3yJ_RULaUiDt0_557vLRsiEVIuUhiWNZvjv77n7nO4DvqGF3RBaJgAs0UYSWSWC6MgtCL12UCS61I9fA8CYe3InrSTSpHW5FHVbZrInlQu2mlnzkxzyMCYFKhDx9eAyoahShq3UJjQ-wQanLKKRLTpYGV6cK8UALhyD-RDVH5xJ5PLzqVakLmysslczl1vTPcbdXWme5-_S34FOtNrKzis7bsObzHdgc1sD4Z_g7_jMlpzc7p5ImNNnsjHDwgpHLD8WY_h7eV1mXZvoEXxdklheMzpewX3Odl6fNcO1jL1JvIEsy7Kr09LO-R3qysaZ8wgUrYw1Y_2o8-AJ3_cvb80FQ11UIrOioWWAyp0XCvVddo6wMhVGRDDMqAKq1zbhxXDtlQ20ii-JqklgobmxXCxeH3lm-C-v5NPdfgWmO5o-nzowT3BmTxdaiBSiU8HGUhS3gzZSmtk46TrUvfqcN-I2ESP8nRAuCxV8PVdKNN9r_QGq9s-lBQ9K0ltYiXfJWC44Wn1HOCDzRuZ_Oi5TqK0lUr9WqNrEi3DmJeAv2KnZZDApVTYl359vqAezDR1TJRBXFdgDrs6e5P0S1Z2baJW-3YaN3efNzhE8Xo-4zBFf8bw
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3da9RAEB_qFdQX8aPqabUrKPQl9JLdZDeCSFt73NnmUK-FvqX7FRDaXDV3iPg_-Tc6k4-rVqi-NJCXZHcJmdnZmfnNB8BL1LAHoohFwAWaKELLNDCRLILQSxcXgkvtyDWQTZLRkXh_HB-vwM8uF4bCKjuZWAtqN7PkI9_iYUIIVCrk2_MvAXWNInS1a6HRsMW-__4NTbbqzfgd0vdVFA33DndHQdtVILBioOaBKZwWKfdeRUZZGQqjYhkW1P5Sa1tw47h2yobaxBaZ1aSJUNzYSAuXhN5ZjuvegFXB0ZTpwerO3uTDp6WJN2iCStCmoqCCVHXJeqncysY7TbHE7gprtfbiMPwjwe4vPbc-74Z34U6rqLLthrPuwYov78PNrIXiH8CP6dmM3Oxsl5qoEHnZNiHvFSMnIwoOmp19buo8zfVrfFyRI6BilNHCPi50Wee3obRlvxX7wE3AcKkaW2BDjxzEppoqGFesjm5gw_F0tAZH1_LPH0KvnJX-MTDN0eDytJhxgjtjisRatDmFEj6Ji7APvPuluW3LnFO3jdO8g9uREPllQvQhWM46b8p8_GP8JlLrP4eudyTNW_lQ5Rfc3IcXy9e4swmu0aWfLaqcOjpJVOjVVWMSRUh3GvM-PGrYZflRqNxKvAdPrv6ADbg1OswO8oPxZP8p3EaFUDQxdOvQm39d-GeodM3N85bTGZxc9-b6Bdu-OkQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Smoking+Cessation+Alters+Intestinal+Microbiota%3A+Insights+from+Quantitative+Investigations+on+Human+Fecal+Samples+Using+FISH&rft.jtitle=Inflammatory+bowel+diseases&rft.au=Biedermann%2C+Luc&rft.au=Br%C3%BClisauer%2C+Karin&rft.au=Zeitz%2C+Jonas&rft.au=Frei%2C+Pascal&rft.date=2014-09-01&rft.pub=Oxford+University+Press&rft.issn=1078-0998&rft.eissn=1536-4844&rft.volume=20&rft.issue=9&rft.spage=1496&rft.epage=1501&rft_id=info:doi/10.1097%2FMIB.0000000000000129&rft.externalDocID=10.1097%2FMIB.0000000000000129
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1078-0998&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1078-0998&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1078-0998&client=summon